Patents by Inventor Maud Urbanski

Maud Urbanski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted indazole-O-glucosides
    Publication number: 20050032711
    Abstract: Substituted indazole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.
    Type: Application
    Filed: July 30, 2004
    Publication date: February 10, 2005
    Inventors: Mona Patel, Philip Rybczynski, Maud Urbanski, Xiaoyan Zhang
  • Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
    Publication number: 20050032712
    Abstract: This invention relates to to substituted benzimidazole-O-glucosides, benztriazole-O-glucosides, and benzimidazolone-O-glucosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
    Type: Application
    Filed: July 30, 2004
    Publication date: February 10, 2005
    Inventor: Maud Urbanski
  • 2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents
    Patent number: 5753715
    Abstract: The invention relates to cyclohexenyl antibacterial compounds of the formula I: ##STR1## and pharmaceutical compositions containing the compounds, methods for their production and use.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: May 19, 1998
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Robert H. Chen, Maud Urbanski, Min Xiang, John Francis Barrett
  • Substituted pyrimidinylaminothiazole derivatives useful as platelet aggregation inhibitors
    Patent number: 5665724
    Abstract: This invention relates to substituted thiazole derivatives of the following general formula, the substituent groups of which are as defined in the specification herein: ##STR1## These compounds are useful as inhibitors of platelet aggregation and inhibitors of adhesion molecules and may be provided in pharmaceutical compositions and in methods of treating reperfusion thrombosis injury in patients. Also included are novel intermediates for preparing the compounds of the invention.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: September 9, 1997
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Pauline J. Sanfilippo, Maud Urbanski
  • Substituted pyrimidinylaminothiazole derivatives useful as platelet aggreggation inhibitors
    Patent number: 5530000
    Abstract: This invention relates to substituted thiazole derivatives of the following general formula, the substituent groups of which are as defined in the specification herein: ##STR1## These compounds are useful as inhibitors of platelet aggregation and inhibitors of adhesion molecules and may be provided in pharmaceutical compositions and in methods of treating reperfusion thrombosis injury in patients. Also included are novel intermediates for preparing the compounds of the invention.
    Type: Grant
    Filed: December 22, 1993
    Date of Patent: June 25, 1996
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Pauline J. Sanfilippo, Maud Urbanski
  • Process for the preparation of enantiomerically pure thienopyran derivatives
    Patent number: 5457212
    Abstract: A process for the preparation of enantiomerically pure thienopyran derivatives of the formula ##STR1## is described. The thienopyran derivatives are relaxants of smooth muscle tone and as such are useful in vascular tissue for the treatment of hypertension disease, angina and other vascular disorders characterized by poor regional perfusion.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: October 10, 1995
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Jeffery B. Press, Pauline J. Sanfilippo, Maud Urbanski
  • Substituted thiazole derivatives useful as platelet aggregation inhibitors
    Patent number: 5342851
    Abstract: This invention relates to substituted thiazole derivatives of the following general formula, the substituent groups of which are as defined herein: ##STR1## These compounds are useful as inhibitors of platelet aggregation and inhibitors of adhesion molecules and may be provided in pharmaceutical compositions and in methods of treating reperfusion thrombosis injury in patients.
    Type: Grant
    Filed: October 7, 1992
    Date of Patent: August 30, 1994
    Assignee: McNeil-PPC, Inc.
    Inventors: Pauline J. Sanfilippo, Maud Urbanski, John R. Carson, Richard J. Carmosin
  • Phenyl and benzoyl substituted imidazo-fused heterocyclic calcium channel blockers
    Patent number: 4880824
    Abstract: Heterocyclic compounds of formulae (I) and (II): ##STR1## where R.sup.1 and R.sup.2 are alkyl, R.sup.3 is H or alkyl, m is 2-5 and Het is a hetercycle such as thiazole, benzothiazole, substituted benzothiazole, pyrazine, triazine, thiadiazole, substituted thiadiazole, pyrimidine or substituted pyrimidine. The compounds are calcium channel blockers useful in the treatment of cardiovascular conditions such as hypertension or angina.
    Type: Grant
    Filed: September 21, 1987
    Date of Patent: November 14, 1989
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Jeffery B. Press, Maud Urbanski
  • 2-substituted-4-aryl-substituted thiazoles
    Patent number: 4791200
    Abstract: The present invention relates to novel 2-substituted-4-aryloxyalkylamine thiazoles as described herein. The thiazoles are useful as antisecretory agents.
    Type: Grant
    Filed: June 22, 1987
    Date of Patent: December 13, 1988
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Jeffery B. Press, Pauline Sanfilippo, Maud Urbanski